Alert share


02 Feb 2023
0.000 (0.0%)
03 Feb 2023
0.000 (0.0%)
2 days ago
+0.005 (+1.0%)
Yesterday
-0.005 (-0.9%)
Today
-0.005 (-1.0%)
Price Change Volume
Buy-Q / Buy Sell / Sell-Q
premium Premium Account Only
Live Quote
5 market depth level
Live intraday chart
Open Day Range Ref
Price Change Volume


Third Interim Dividend

PHARMANIAGA BERHAD

Entitlement subject Third Interim Dividend
Entitlement description
Third Interim Dividend of 0.6 sen
Ex-Date 08 Dec 2022
Entitlement date 09 Dec 2022
Entitlement time 5:00 PM
Financial Year End 31 Dec 2022
Period
Share transfer book & register of members will be 09 Dec 2022 to 09 Dec 2022 closed from (both dates inclusive) for the purpose of determining the entitlement
Payment Date 22 Feb 2023
a.Securities transferred into the Depositor's Securities Account before 4:30 pm in respect of transfers 09 Dec 2022
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units)
(If applicable)
Entitlement indicator Currency
Announced Currency Malaysian Ringgit (MYR)
Disbursed Currency Malaysian Ringgit (MYR)
Entitlement in Currency Malaysian Ringgit (MYR) 0.0060

Par Value (if applicable) Malaysian Ringgit (MYR) 0.0000
Registrar or Service Provider name, address, telephone no TRICOR INVESTOR & ISSUING HOUSE SERVICES SDN BHD
Unit 32-01, Level 32, Tower A,
Vertical Business Suite, Avenue 3, Bangsar South,

No. 8, Jalan Kerinchi

59200 Kuala Lumpur

Wilayah Persekutuan

Malaysia

Tel:0327839299
Fax:0327839222



Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 24 Nov 2022
Category Entitlement(Notice of Book Closure)
Reference Number ENT-21112022-00007
Corporate Action ID MY221121DVCA0007


Overview Market Search portfolio More
Overview Market Search Portfolio More
Shariah SettingShariah: Off
Screen ArrangementScreen Arrangement
Recently Viewed